HomeACIU • NASDAQ
AC Immune SA
add
$1.72
2.99%
After Hours:(0.00%)0.00
$1.72
Closed: May 2, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 990.00K | — |
Operating expense | 20.36M | 315.26% |
Net income | -19.03M | -6.53% |
Net profit margin | -1.92K | — |
Earnings per share | -0.19 | -5.56% |
EBITDA | -19.00M | 3.46% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 145.61M | 38.92% |
Total assets | 211.08M | 26.18% |
Total liabilities | 116.28M | 414.53% |
Total equity | 94.80M | — |
Shares outstanding | 100.15M | — |
Price to book | 1.76 | — |
Return on assets | -21.91% | — |
Return on capital | -44.49% | — |
Cash Flow
Net Change in Cash
Net change in cash
(CHF) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -19.03M | -6.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$1.67
Day range
$1.69 - $1.79
Year range
$1.43 - $4.98
Market cap
172.71M USD
Avg Volume
184.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
153